NICOLE WOTUS-SILVESTRI: Open Payments
NPI 1508938481 · NEWARK, DE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,349 in 87 payments from 13 companies in 2025. Trend: 2023 $2,571 · 2024 $1,715 · 2025 $1,349
Food & beverage: $1,267Education: $82
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 20 | $322 |
| Janssen Biotech, Inc. | 16 | $209 |
| UCB, Inc. | 14 | $169 |
| Galderma Laboratories, L.P. | 9 | $166 |
| Novartis Pharmaceuticals Corporation | 10 | $148 |
| Amgen Inc. | 6 | $136 |
| Regeneron Healthcare Solutions, Inc. | 2 | $42 |
| Journey Medical Corporation | 2 | $38 |
| MAYNE PHARMA COMMERCIAL LLC | 4 | $37 |
| Verrica Pharmaceuticals Inc. | 1 | $24 |
Products named: RINVOQ, TREMFYA, Bimzelx, NEMLUVIO, OTEZLA, COSENTYX, SKYRIZI, DUPIXENT.
Industry payments across DE — which companies pay providers there.
